• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Bright.md Integrates with GOeVisit, Enters Canadian Market with Virtual Care Platform

by Fred Pennic 07/13/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Bright.md Lands $8M for Virtual Physician Assistant, Partners with Adventist Health System

This week, Bright.md announced a new and unique customer deployment with Vancouver-based MyCare MedTech, marking its initial expansion into the global marketplace. Until now, the company’s SmartExam platform has been implemented exclusively by traditional brick and mortar healthcare systems like Providence Health & Services, Presbyterian Health Systems and Rush University. However MyCare MedTech tapped Bright.md to enhance its own existing virtual platform, dubbed GOeVisit.

SmartExam enables users to connect with medical practitioners via any smart device to be treated for 400+ minor illnesses and injuries, leveraging AI to conduct clinical interviews and identify low acuity common conditions more efficiently. In fact, most virtual visits can be conducted in two minutes or less.

“The decision to move to this platform was an easy one; it is a superior service that allows us to continue to offer Canadians a unique way to gain access to medical care.” said Liz Bryant, Chief Operating Officer at GOeVisit. “GOeVisit SmartExam is a user-friendly service that has the ability to keep pace with and integrate new and improved technologies in the coming years. We are confident it will outperform all existing virtual healthcare platforms in the market today.”

SmartExam’s artificial intelligence capabilities act as a virtual physician’s assistant, dynamically conducting a clinical interview and using the patients’ answers to gather relevant information to support medical providers in the delivery of virtual care.

 

It provides Canadians with quality care that is private, secure, fast, affordable and convenient. Accessible from anywhere and any device, SmartExam is fully-automated, meaning prescriptions are sent to a pharmacy of choice and the patient summary is sent directly to the patient via a secure link.

 

“With GOevisit SmartExam, we wanted to offer virtual care that provides a high-quality experience for both the patient and the clinician, and allows for continuous improvement,” said Dr. Raj Attariwala, Medical Director of AIM Medical Imaging and Medical Director of GOeVisit. “Medical technology doesn’t stand still, and neither can we.”

Canadians have been receiving care via GOeVisit SmartExam since the beginning of July, joining the millions of healthcare consumers already experiencing the benefits of SmartExam from leading healthcare systems around the United States.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Bright.md, Virtual Care, Virtual Care Platform

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |